Trials / Completed
CompletedNCT00054795
Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)
Randomized Phase III Trial of Xcytrin® (Motexafin Gadolinium) Injection for the Treatment of Brain Metastases in Patients With Non-Small Cell Lung Cancer Undergoing Whole Brain Radiation Therapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 550 (planned)
- Sponsor
- Pharmacyclics LLC. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of the study is to determine if patients with brain metastases from non-small cell lung cancer treated with Motexafin Gadolinium and whole brain radiation therapy retain their neurologic function and ability to think for a longer time compared to patients treated with whole brain radiation therapy alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Motexafin Gadolinium |
Timeline
- First posted
- 2003-02-13
- Last updated
- 2007-05-08
Locations
92 sites across 8 countries: United States, Australia, Austria, Belgium, Canada, France, Germany, Netherlands
Source: ClinicalTrials.gov record NCT00054795. Inclusion in this directory is not an endorsement.